Lantus 100 [iU]/mL
insulin glargine · INJECTION, SOLUTION · sanofi-aventis U.S. LLC
No Recall HistoryCurrently in Shortage
Plain English
Lantus is a injection, solution containing insulin glargine at 100 [iU]/mL, taken subcutaneous. Manufactured by sanofi-aventis U.S. LLC.
Key Facts
- Brand Name
- Lantus
- Generic Name
- insulin glargine
- NDC Code (Product)
0088-2220- Manufacturer
- sanofi-aventis U.S. LLC
- Strength
- 100 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA021081
- Drug Class
- Insulin Analog [EPC]
- Marketing Start
- 09/23/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is Lantus used for?
Lantus contains insulin glargine. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Lantus a controlled substance?
Lantus is not classified as a controlled substance by the DEA.
What is the generic name for Lantus?
The generic name for Lantus is insulin glargine. There are 11 other brand versions of insulin glargine.
What is the NDC code for Lantus 100 [iU]/mL?
The NDC (National Drug Code) for Lantus 100 [iU]/mL is 0088-2220, listed by sanofi-aventis U.S. LLC.
Other Lantus Dosages
Other Insulin Brands
See all →- Insulin Glargine100 [iU]/mL83257-015
- BASAGLAR Tempo Pen100 [iU]/mL0002-8214
- TOUJEO Max300 U/mL0024-5871
- INSULIN GLARGINE100 [iU]/mL72572-424
- SEMGLEE100 [iU]/mL83257-012
- LANTUS SOLOSTAR100 [iU]/mL50090-4068
- REZVOGLAR KWIKPEN100 [iU]/mL50090-6439
- Insulin Glargine100 [iU]/mL83257-014
- TOUJEO300 U/mL0024-5869
- Insulin glargine U-300 Max300 [iU]/mL0955-2900
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)